Shapiro, A. M., Pokrywczynska, M. & Ricordi, C. Clinical pancreatic islet transplantation. Nat. Rev. Endocrinol. 13, 268–277 (2017).
Google Scholar
Molano, R. D. et al. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. Transplantation 75, 1812–1819 (2003).
Google Scholar
Shapiro, A. M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230–238 (2000).
Google Scholar
Rapamune (sirolimus) [Package Insert]. Wyeth Pharmaceuticals, Collegeville, PA (2011).
Halloran, P. F. Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351, 2715–2729 (2004).
Google Scholar
Yatscoff, R. W., Wang, P., Chan, K., Hicks, D. & Zimmerman, J. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations. Ther. Drug Monit. 17, 666–671 (1995).
Google Scholar
Ferron, G. M., Mishina, E. V., Zimmerman, J. J. & Jusko, W. J. Population pharmacokinetics of sirolimus in kidney transplant patients. Clin. Pharmacol. Ther. 61, 416–428 (1997).
Google Scholar
Meier-Kriesche, H. U. & Kaplan, B. Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations. Clin. Ther. 22, B93–B100 (2000).
Google Scholar
Hafiz, M. M. et al. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation 80, 1718–1728 (2005).
Google Scholar
Lombardi, G. & Vasquez, Y. in Handbook of Experimental Pharmacology, Vol. 188 (eds Lombardi, G. & Vasquez, Y.) Preface (Springer, 2009).
Stabler, C. L., Li, Y., Stewart, J. M. & Keselowsky, B. C. Engineering immunomodulatory biomaterials for type 1 diabetes. Nat. Rev. Mater. 4, 429–450 (2019).
Google Scholar
Emoto, C., Fukuda, T., Cox, S., Christians, U. & Vinks, A. A. Development of a physiologically-based pharmacokinetic model for sirolimus: predicting bioavailability based on intestinal CYP3A content. CPT Pharmacometrics Syst. Pharmacol. 2, e59 (2013).
Google Scholar
Haeri, A., Osouli, M., Bayat, F., Alavi, S. & Dadashzadeh, S. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies. Artif. Cells Nanomed. Biotechnol. 46, 1–14 (2018).
Google Scholar
Alemdar, A. Y., Baker, K. A., Sadi, D., McAlister, V. C. & Mendez, I. Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats. Exp. Neurol. 172, 416–424 (2001).
Google Scholar
Haeri, A. et al. Use of remote film loading methodology to entrap sirolimus into liposomes: preparation, characterization and in vivo efficacy for treatment of restenosis. Int. J. Pharm. 414, 16–27 (2011).
Google Scholar
Allen, S., Osorio, O., Liu, Y. G. & Scott, E. Facile assembly and loading of theranostic polymersomes via multi-impingement flash nanoprecipitation. J. Control. Release 262, 91–103 (2017).
Google Scholar
Allen, S. D. et al. Polymersomes scalably fabricated via flash nanoprecipitation are non-toxic in non-human primates and associate with leukocytes in the spleen and kidney following intravenous administration. Nano Res. https://doi.org/10.1007/s12274-018-2069-x (2018).
Stano, A., Scott, E. A., Dane, K. Y., Swartz, M. A. & Hubbell, J. A. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles. Biomaterials 34, 4339–4346 (2013).
Google Scholar
Scott, E. A. et al. Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Biomaterials 33, 6211–6219 (2012).
Google Scholar
Dowling, D. J. et al. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses. J. Allergy Clin. Immunol. 140, 1339–1350 (2017).
Google Scholar
Yi, S. et al. Tailoring nanostructure morphology for enhanced targeting of dendritic cells in atherosclerosis. ACS Nano 10, 11290–11303 (2016).
Google Scholar
Bracho-Sanchez, E., Hassanzadeh, A., Brusko, M. A., Wallet, M. A. & Keselowsky, B. G. Dendritic cells treated with exogenous indoleamine 2,3-dioxygenase maintain an immature phenotype and suppress antigen-specific T cell proliferation. J. Immunol. Regen. Med. https://doi.org/10.1016/j.regen.2019.100015 (2019).
Peng, Y., Latchman, Y. & Elkon, K. B. Ly6Clow monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1. J. Immunol. 182, 2777–2785 (2009).
Google Scholar
Allen, R. P., Bolandparvaz, A., Ma, J. A., Manickam, V. A. & Lewis, J. S. Latent, immunosuppressive nature of poly(lactic-co-glycolic acid) microparticles. ACS Biomater. Sci. Eng. 4, 900–918 (2018).
Google Scholar
Zhang, N. et al. Sirolimus is associated with reduced islet engraftment and impaired β-cell function. Diabetes 55, 2429–2436 (2006).
Google Scholar
Rosborough, B. R. et al. Adenosine triphosphate-competitive mTOR inhibitors: a new class of immunosuppressive agents that inhibit allograft rejection. Am. J. Transpl. 14, 2173–2180 (2014).
Google Scholar
van den Bosch, T. P., Kannegieter, N. M., Hesselink, D. A., Baan, C. C. & Rowshani, A. T. Targeting the monocyte-macrophage lineage in solid organ transplantation. Front. Immunol. 8, 153 (2017).
Abbas, A. K. & Lichtman, A. H. Basic Immunology: Functions and Disorders of the Immune System 2nd edn (Saunders, 2004).
Cantarelli, E. et al. Murine animal models for preclinical islet transplantation: no model fits all (research purposes). Islets 5, 79–86 (2013).
Mahe, E. et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation 79, 476–482 (2005).
Google Scholar
Ventola, C. L. Progress in nanomedicine: approved and investigational nanodrugs. P T 42, 742–755 (2017).
Burrack, A. L., Martinov, T. & Fife, B. T. T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes. Front. Endocrinol. (Lausanne) 8, 343 (2017).
Bouhdoud, L., Villain, P., Merzouki, A., Arella, M. & Couture, C. T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4+ cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide. J. Virol. 74, 2121–2130 (2000).
Google Scholar
Vieyra-Lobato, M. R., Vela-Ojeda, J., Montiel-Cervantes, L., Lopez-Santiago, R. & Moreno-Lafont, M. C. Description of CD8+ regulatory T lymphocytes and their specific intervention in graft-versus-host and infectious diseases, autoimmunity, and cancer. J. Immunol. Res. 2018, 3758713 (2018).
Fu, C. et al. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes. Proc. Natl Acad. Sci. USA 117, 23730–23741 (2020).
Google Scholar
Thomas, H. E., Darwiche, R., Corbett, J. A. & Kay, T. W. Interleukin-1 plus γ-interferon-induced pancreatic β-cell dysfunction is mediated by β-cell nitric oxide production. Diabetes 51, 311–316 (2002).
Google Scholar
Kawamura, S. & Ohteki, T. Monopoiesis in humans and mice. Int. Immunol. 30, 503–509 (2018).
Google Scholar
Zhu, J., Chen, H., Huang, X., Jiang, S. & Yang, Y. Ly6Chi monocytes regulate T cell responses in viral hepatitis. JCI Insight 1, e89880 (2016).
Parrot, T. et al. Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive ɑβ T cells in melanoma. Sci. Rep. 10, 5900 (2020).
Google Scholar
Parel, Y. et al. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum. 56, 3459–3467 (2007).
Google Scholar
Overgaard, N. H., Jung, J. W., Steptoe, R. J. & Wells, J. W. CD4+/CD8+ double-positive T cells: more than just a developmental stage? J. Leukoc. Biol. 97, 31–38 (2015).
Dew, M. A. et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 83, 858–873 (2007).
Nulojix (belatacept) [Package Insert]. Bristol Myers Squibb, Princeton, NJ (2011).
O’Hare, F. M. et al. Neutrophil and monocyte toll-like receptor 4, CD11b and reactive oxygen intermediates, and neuroimaging outcomes in preterm infants. Pediatr. Res. 78, 82–90 (2015).
Yasunami, Y. et al. Vɑ14 NK T cell-triggered IFN-γ production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. J. Exp. Med. 202, 913–918 (2005).
Google Scholar
Manzoli, V. et al. Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol. Am. J. Transpl. 18, 590–603 (2018).
Google Scholar
Allen, S. D., Bobbala, S., Karabin, N. B., Modak, M. & Scott, E. A. Benchmarking bicontinuous nanospheres against polymersomes for in vivo biodistribution and dual intracellular delivery of lipophilic and water-soluble payloads. ACS Appl. Mater. Interfaces 10, 33857–33866 (2018).
Google Scholar
Yu, Y. R. et al. A protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues. PLoS ONE 11, e0150606 (2016).
Belkina, A. C. et al. Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets. Nat. Commun. 10, 5415 (2019).
Andrews, S. FastQC: a quality control tool for high throughput sequence data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc (Babraham Bioinformatics, 2010).
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
Google Scholar
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Google Scholar
Trapnell, C. et al. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 (2010).
Google Scholar
Trapnell, C. et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31, 46–53 (2013).
Google Scholar
Roberts, A., Trapnell, C., Donaghey, J., Rinn, J. L. & Pachter, L. Improving RNA-seq expression estimates by correcting for fragment bias. Genome Biol. 12, R22 (2011).
Google Scholar
